Mikel Sánchez1,2, Diego Delgado2, Orlando Pompei1, Juan Carlos Pérez1, Pello Sánchez2, Ane Garate2, Ane Miren Bilbao1, Nicolás Fiz1, Sabino Padilla3. 1. 1 Arthroscopic Surgery Unit, Hospital Vithas San José, Vitoria-Gasteiz, Spain. 2. 2 Advanced Biological Therapy Unit, Hospital Vithas San José, Vitoria-Gasteiz, Spain. 3. 3 University Institute for Regenerative Medicine & Oral Implantology - UIRMI (UPV/EHU-Fundacion Eduardo Anitua), C/Jacinto Quincoces, Vitoria-Gasteiz, Álava, Spain.
Abstract
OBJECTIVE: Assessing the therapeutic effects of a combination of intra-articular and intra-osseous infiltrations of platelet-rich plasma (PRP) to treat severe knee osteoarthritis (KOA) using intra-articular injections of PRP as the control group. DESIGN: In this observational study, 60 patients suffering from severe KOA were treated with intra-articular infiltrations of PRP (IA group) or with a combination of intra-osseous and intra-articular infiltrations of PRP (IO group). Both groups were matched for sex, age, body mass index, and radiographic severity (III and IV degree according to Ahlbäck scale). Clinical outcome was evaluated at 2, 6, and 12 months, using the Knee injury and Osteoarthritis Outcome Score (KOOS) and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) questionnaires. RESULTS: At 2, 6 and 12 months after treatment, IO group had a significant improvement in all KOOS and WOMAC subscales ( P < 0.05). On the contrary, patients of the IA group did not improve in any of the scores. Sixteen out of 30 IO group patients showed minimal clinically important improvement (MCII) whereas 8 out of 30 IA group patients showed this response at 6 months (26.7%; 95% CI -0.4 to 49.9; P = 0.037). At 12 months, 14 patients of IO group and 5 patients of the IA group showed MCII (30%; 95% CI 4.3 to 51.9; P = 0.013). No differences between groups were observed at 2 months. CONCLUSIONS: PRP intra-articular injections in severe KOA were not effective and did not provide any benefit. Combination of intra-articular and intra-osseous infiltrations of PRP was not clinically superior at 2 months, but it showed superior clinical outcomes at 6 and 12 months when compared with intra-articular injections of PRP.
OBJECTIVE: Assessing the therapeutic effects of a combination of intra-articular and intra-osseous infiltrations of platelet-rich plasma (PRP) to treat severe knee osteoarthritis (KOA) using intra-articular injections of PRP as the control group. DESIGN: In this observational study, 60 patients suffering from severe KOA were treated with intra-articular infiltrations of PRP (IA group) or with a combination of intra-osseous and intra-articular infiltrations of PRP (IO group). Both groups were matched for sex, age, body mass index, and radiographic severity (III and IV degree according to Ahlbäck scale). Clinical outcome was evaluated at 2, 6, and 12 months, using the Knee injury and Osteoarthritis Outcome Score (KOOS) and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) questionnaires. RESULTS: At 2, 6 and 12 months after treatment, IO group had a significant improvement in all KOOS and WOMAC subscales ( P < 0.05). On the contrary, patients of the IA group did not improve in any of the scores. Sixteen out of 30 IO group patients showed minimal clinically important improvement (MCII) whereas 8 out of 30 IA group patients showed this response at 6 months (26.7%; 95% CI -0.4 to 49.9; P = 0.037). At 12 months, 14 patients of IO group and 5 patients of the IA group showed MCII (30%; 95% CI 4.3 to 51.9; P = 0.013). No differences between groups were observed at 2 months. CONCLUSIONS:PRPintra-articular injections in severe KOA were not effective and did not provide any benefit. Combination of intra-articular and intra-osseous infiltrations of PRP was not clinically superior at 2 months, but it showed superior clinical outcomes at 6 and 12 months when compared with intra-articular injections of PRP.
Entities:
Keywords:
intra-osseous infiltration; knee osteoarthritis; platelet-rich plasma; subchondral bone
Authors: Carlos J Meheux; Patrick C McCulloch; David M Lintner; Kevin E Varner; Joshua D Harris Journal: Arthroscopy Date: 2015-10-01 Impact factor: 4.772
Authors: Andrew J Barr; T Mark Campbell; Devan Hopkinson; Sarah R Kingsbury; Mike A Bowes; Philip G Conaghan Journal: Arthritis Res Ther Date: 2015-08-25 Impact factor: 5.156
Authors: Corey W Hunter; Timothy R Deer; Mark R Jones; George C Chang Chien; Ryan S D'Souza; Timothy Davis; Erica R Eldon; Michael F Esposito; Johnathan H Goree; Lissa Hewan-Lowe; Jillian A Maloney; Anthony J Mazzola; John S Michels; Annie Layno-Moses; Shachi Patel; Jeanmarie Tari; Jacqueline S Weisbein; Krista A Goulding; Anikar Chhabra; Jeffrey Hassebrock; Chris Wie; Douglas Beall; Dawood Sayed; Natalie Strand Journal: J Pain Res Date: 2022-09-08 Impact factor: 2.832
Authors: Payal Ganguly; Nicolás Fiz; Maider Beitia; Heather E Owston; Diego Delgado; Elena Jones; Mikel Sánchez Journal: J Clin Med Date: 2022-07-04 Impact factor: 4.964
Authors: Berardo Di Matteo; Alberto Polignano; Francesco Onorato; Agostino La Porta; Francesco Iacono; Tommaso Bonanzinga; Giovanni Raspugli; Maurilio Marcacci; Elizaveta Kon Journal: Cartilage Date: 2020-09-22 Impact factor: 3.117
Authors: Marta Torres-Torrillas; Elena Damiá; José J Cerón; José M Carrillo; Pau Peláez; Laura Miguel; Ayla Del Romero; Mónica Rubio; Joaquín J Sopena Journal: Cartilage Date: 2021-12-03 Impact factor: 3.117